Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.
about
Network structure of brain atrophy in de novo Parkinson's diseaseLRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative studyNeuropathology of non-Alzheimer degenerative disordersBenign tremulous Parkinsonism: a unique entity or another facet of Parkinson's disease?Brainstem and spinal cord circuitry regulating REM sleep and muscle atoniaPropagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Parkinson's disease as a result of agingCircadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse modelParkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisAltered Spontaneous Brain Activity in Cortical and Subcortical Regions in Parkinson's DiseaseVoice and fluency changes as a function of speech task and deep brain stimulation.Fatigue in levodopa-naive subjects with Parkinson disease.Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognitionIntramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice.The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.Hippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models.Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.Prion-like transmission of protein aggregates in neurodegenerative diseasesThe contribution of neuroimaging for the study of cognitive deficits in Parkinson's disease.Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.A Life-Long Approach to Physical Activity for Brain Health.Embryonic development of selectively vulnerable neurons in Parkinson's disease.Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.Cell based therapies in Parkinson's Disease.Brain disposition of α-Synuclein: roles of brain barrier systems and implications for Parkinson's disease.Movement disorders: role of imaging in diagnosis.Individual and joint prevalence of three nonmotor symptoms of PD in the US general populationTreatment of dysautonomia in extrapyramidal disordersA novel neuroprotective therapy for Parkinson's disease using a viral noncoding RNA that protects mitochondrial complex I activity.The black stuff and Konstantin Nikolaevich Tretiakoff.Pathophysiology of parkinsonism.Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expressionAlterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.Altered intrinsic functional coupling between core neurocognitive networks in Parkinson's disease.Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosisα-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson diseaseOlfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairmentAltered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication
P2860
Q23890444-82705988-23ED-444E-8EA7-7D48F3173BDBQ24307455-7D1EA8CA-7F55-4D3A-988B-089B47F14A20Q24657571-0EBA7D3C-DD95-47F3-B2E9-E03D62AD93B7Q26747010-20B019EB-8420-479A-81B9-95BD587CDEA0Q27319697-12356E5E-12A6-402E-B339-7B2AF27220DDQ27322513-2C258522-21A1-4D30-91E0-4D30A5D78384Q28084395-197A1235-B869-4843-8266-92ECD5E0CE82Q28384426-C5E392E2-9E37-441A-BE28-22EE5A9CA091Q28384572-676CE421-15C3-40A1-A723-B4EAEF2D113CQ28596860-96EA28A9-0898-4662-B07F-3A212537A17DQ30417282-1E2FF86E-EA83-472B-8A9B-7C9A1BD18B18Q30434565-45865AA0-9758-457C-B168-659437244A4BQ30482965-9CC08176-90F6-426D-8662-9120243BEA69Q30585365-CB4140A8-700A-445D-9ABB-8F37F7C46864Q31008210-582A46EF-62D0-4A0E-B742-3ED061BDD00DQ31060511-ECD0F740-3D7C-4C9D-A328-608329847023Q33323265-7913309C-1D32-46AB-8C05-ED4AFB6002DDQ33544162-2984815A-68DA-4F20-ABFA-C5BC344A300DQ33593378-0FBB81C7-805A-4154-A944-F270AEEF08EEQ33647059-9A6EFFD5-B8C3-46D6-850F-DBD959F19C85Q33715695-B885F641-E9E5-4131-90DC-247E24ED19C8Q33835242-A597F470-1B82-49C1-853D-82221E922A9CQ33835599-051334E1-0859-4E1E-B99D-548B02368C3BQ33979529-C5E7BD8C-F221-4B11-B13E-90ADD4B92D8DQ33997655-2CE0C7B6-5176-4532-A5B0-566D7FB1491BQ34136898-CA85B96D-BE1E-457A-8BCB-F17FE8C487DAQ34281376-9AB8C646-9BFD-4A3B-A54B-D247E49D92EAQ34409285-ED080D84-4147-43BA-9FD4-F23E392C0AF3Q34634457-68F51334-E74E-4C55-B3D5-9D8D6F9F08A2Q34766872-DE632EEE-1EDB-4259-AEB7-58B0A3732296Q34777496-5F919ED3-8D16-4BD9-AA95-F1DBA2312BD9Q34991077-45B1CD59-0BE9-41C5-BA2A-ABAE06D57F93Q35053448-294780B2-DE4E-4286-B6C0-B0580148BC8FQ35059334-07B2936C-913C-48F1-9776-A8EEC7FEA626Q35066107-5B2C4658-0AC5-4D0D-8B18-8021C6963770Q35100189-4777AE69-9927-4256-B62D-8DFCE3DE66D6Q35201409-C4F57BEE-105A-4DE4-BC30-D58FEAF2B039Q35212580-57A7587D-4E9D-4E3F-9D6A-D9AFA267E069Q35266392-C4C053E6-2A14-41DE-B9E3-F0FCA33135ACQ35516259-6B53CE0B-561B-4D92-AB43-E0B2BA2244D0
P2860
Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Stanley Fahn Lecture 2005: The ...... kinson's disease reconsidered.
@ast
Stanley Fahn Lecture 2005: The ...... kinson's disease reconsidered.
@en
type
label
Stanley Fahn Lecture 2005: The ...... kinson's disease reconsidered.
@ast
Stanley Fahn Lecture 2005: The ...... kinson's disease reconsidered.
@en
prefLabel
Stanley Fahn Lecture 2005: The ...... kinson's disease reconsidered.
@ast
Stanley Fahn Lecture 2005: The ...... kinson's disease reconsidered.
@en
P2093
P2860
P356
P1433
P1476
Stanley Fahn Lecture 2005: The ...... kinson's disease reconsidered.
@en
P2093
Christian M Müller
Heiko Braak
Jürgen R Bohl
Kelly Del Tredici
Rob A I de Vos
P2860
P304
P356
10.1002/MDS.21065
P407
P577
2006-12-01T00:00:00Z